| Line Item | 2026-01-30 | Y/Y |
|---|---|---|
| Revenue | $7.26B | -2.9% |
| Cost of Revenue | $6.39B | -3.0% |
| R&D Expense | $13.0M | +8.3% |
| SG&A Expense | $350.0M | +3.2% |
| Operating Income | $521.0M | -7.5% |
| Pre-tax Income | $387.0M | -9.6% |
| Income Tax | $29.0M | -56.1% |
| Net Income | $358.0M | -1.1% |
| EPS (Basic) | $7.73 | +6.9% |
| EPS (Diluted) | $7.70 | +7.4% |
| Line Item | 2026-01-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $182.0M | +225.0% |
| Accounts Receivable | $853.0M | -14.7% |
| Current Assets | $1.18B | +2.2% |
| Total Assets | $5.35B | +2.1% |
| Current Liabilities | $982.0M | -29.7% |
| Long-term Debt | $2.49B | +12.0% |
| Stockholders' Equity | $1.50B | -4.9% |
| Line Item | 2026-01-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $609.0M | +23.3% |
| Capital Expenditures | $32.0M | -11.1% |
| Investing Cash Flow | -$248.0M | -608.6% |
| Financing Cash Flow | -$235.0M | +52.8% |
| Free Cash Flow | $577.0M | +26.0% |